Last reviewed · How we verify
Actuate Therapeutics Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
2 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Oncology · 2
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- American Genomics, LLC · 1 shared drug class
- City of Hope Medical Center · 1 shared drug class
- Cooperative Study Group A for Hematology · 1 shared drug class
- Genzyme, a Sanofi Company · 1 shared drug class
- Hospices Civils de Lyon · 1 shared drug class
- Innovent Biologics (Suzhou) Co. Ltd. · 1 shared drug class
- Osaka Medical Center for Cancer and Cardiovascular Diseases · 1 shared drug class
- Tanabe Pharma Corporation · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Actuate Therapeutics Inc.:
- Actuate Therapeutics Inc. pipeline updates — RSS
- Actuate Therapeutics Inc. pipeline updates — Atom
- Actuate Therapeutics Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Actuate Therapeutics Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/actuate-therapeutics-inc. Accessed 2026-05-16.